Cargando…
Underlying Mechanisms of Bergenia spp. to Treat Hepatocellular Carcinoma Using an Integrated Network Pharmacology and Molecular Docking Approach
Hepatocellular carcinoma (HCC) is the fifth most common and fatal cancer reported, representing 72.5% of malignancies around the world. The majority of HCC incidents have been associated with infections caused by hepatitis B and C viruses. Many first- and second-line conventional drugs, e.g., sorafe...
Autores principales: | Hussain, Shoukat, Mustafa, Ghulam, Ahmed, Sibtain, Albeshr, Mohammed Fahad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535166/ https://www.ncbi.nlm.nih.gov/pubmed/37765047 http://dx.doi.org/10.3390/ph16091239 |
Ejemplares similares
-
Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9
por: Mustafa, Ghulam, et al.
Publicado: (2023) -
Bergenia Genus: Traditional Uses, Phytochemistry and Pharmacology
por: Koul, Bhupendra, et al.
Publicado: (2020) -
The traditional uses, phytochemistry, pharmacology and toxicology of Bergenia purparescens: A review comments and suggestions
por: Liu, Yi, et al.
Publicado: (2023) -
Bergenia pacumbis from Nepal, an astonishing enzymes inhibitor
por: Pandey, Bishnu Prasad, et al.
Publicado: (2020) -
Inhibition of calcium oxalate crystallisation in vitro by an extract of Bergenia ciliata
por: Saha, Sarmistha, et al.
Publicado: (2013)